Tuesday,
20 June 2023
9:00 – 11:00
Opening Ceremony
Sin-Hyeog Im
POSTECH & ImmunoBiome Inc., South Korea
Evolution of Probiotic Science
20 Years in the Making – End of the Beginning?
George Paraskevakos
International Probiotic Association, Canada
Probiotic Business Framework Overview
Elinor McCartney
Argenta, Spain
EU, EFSA and Innovation in the Food Chain – 2000 to 2050. What’s Next?
11:00 – 11:30
Coffee Break
Live Biotherapeutic Products
Philippe Langella
INRA, France
Our Intestinal Microbiota as a Source of Live Biotherapeutics for Animal and Human Health
Jonna Koper
Lesaffre International, Lesaffre IST, France
Impact of Faecalibacterium Sp. on Modulation of The Human Gut Microbiota Using The In Vitro Simulator of The Human Microbial Ecosystem (SHIME)
Marco Van Es
Bac2nature foundation, the Netherlands
An Understanding of the One Health – Holomicrobiome Evidence Elevates the Microbiome Field. Human Microbiomes Show Our Inseparable Connection With “Nature”
13:00 – 14:00
Lunch Break
ILSI Europe session: Emerging concepts of host-microbe interactions and its molecular implications for probiotic administration. The ecology and physiology of the small intestine versus the colon: potential consequences for probiotic administration
Daisy Jonkers
Maastricht University, the Netherlands
Introduction on Host-Microbiome Interactions in the Small Versus Large Intestine
Benjamin A. H. Jensen
University of Copenhagen, Denmark
Diet Dependency in Probiotic Efficacy
Christian Sina
University of Lübeck, Germany
Therapeutic Potential of the Intestinal Microbiota in functional GI Diseases
Hands-on Workshop
Introduction Into Basic Experimental Procedures With EpiIntestinal
A Reconstructed 3D Model Of Human Intestinal Epitheliuma
Limited to 30 participants only
16:00 – 16:30
Coffee Break
Market, where to Next?
Ewa Hudson
Lumina Intelligence, United Kingdom
The European E-commerce Market of Probiotics, Prebiotics and Postbiotics – Companies, Products, Benefits, Reviews
Nina Vinot
TargEDys, France
The Importance of the Mechanism of Action in Probiotics Development
Elisabetta Caselli
University of Ferrara, Italy
Probiotic Sanitation as a Sustainable Tool for IPC and AMR Control
Gustav Lindved
Clinical Microbiomics, Denmark
Microbiota Engraftment and Deep Strain Characterization: Novel Tools for Probiotic Design and Development to Reduce Cost, Risk and Time-to-Market
Bodo Speckmann
Evonik Operations GmbH, Germany
Enhancing Gluten Degradation in Humans through a Novel Probiotic Consortium of Lactobacillus and Bacillus Strains
Karl Alex Hedin
Technical Universtiy of Denmark, Denmark
Unlocking the Potential of Probiotics: Genetically Engineering Saccharomyces boulardii for Effective Obesity Management
Science & Industry Connections
Tell us in 3 minutes what are you doing and which partner, capacity, competence are you looking for or offering
Immunology Workshop
Lecturer:
Sin-Hyeog Im: POSTECH & ImmunoBiome Inc.,
South Korea
Probiotic Components in Modulating the Host Immune Response
- How to identify and characterize the immunological properties of specific probiotic strains?
- What are the effector molecules and their mode of action?
- What are the key components of probiotics in communicating with the host’s immune system?
18:40
Networking Bar
Meet those who are seeking for partners or speakers from the programme and have a drink and chat together
Wednesday, 21 June 2023
09:00 – 10:35
Functional Foods, Infant Nutrition, HMO’s
Gwenael Jan
STLO- INRAE- Institut Agro, Microbiology, France
Beneficial Propionibacteria: from Traditional Cheeses to Next Generation Probiotics
Bernd Stahl
Danone Nutricia Research, the Netherlands
HMOS: Great Food for the Little Ones
Jiri Hrdy
Faculty of Medicine – Charles University, Czech Republic
Early Postnatal Supplementation of Newborns by Probiotic Strain E. coli O83:K24:H31 and Its Effect on Allergy Incidence, Selected Immune Charateristics and Microbiota
Adrienne Weiss
Yili Innovation Center Europe, the Netherlands
Lacticaseibacillus Paracasei subsp. Paracasei Strain K56 Reduces Metabolic Effects In Obese Individuals
Simon Aloo
Kangwon National University, South Korea
Protective Effect of Fermented Hempseed Extracts Against Obesity and Obesity-induced Oxidative Stress and Neurodegenerative Disorders
Ashwinipriyadarshini Megur
Vilnius University, Lithuania
In Vitro Screening and Characterization of Lactic Acid Bacteria from Lithuanian Fermented Food with Potential Probiotic Properties
Bacteriocins and Antimicrobial Peptides Symposium BAMP2023
Svetoslav Todorov
Sao Paulo University, ProBacLab, Brazil
Multitasking as Primary Objective in the Selection of Beneficial Microorganisms, Complex Screening Approach
Paul Cotter
Teagasc Food Research Centre, Ireland
Targeting Specific Components of Microbiomes through Natural and Engineered Antimicrobial Peptides
Valentína Focková
Centre of Biosciences of the Slovak Academy of Science, Slovakia
Experimental Application of Mundticin-Like Substance EM 41/3 in Horses of the Breed Norik
10:35 – 11:05
Coffee Break
Ton Baars
Utrecht University, Immunopharmacology, Germany
Immunological Impact and Bio-Active Peptides of Kefir Made from Starter Culture or Back-Slopped Grains Depend on Heat Treatment of the Cow Milk Used
Humberto Martinez Montoya
Universidad Autónoma de Tamaulipas, Mexico
Genomic Features of Lactiplantibacillus sp. and Lacticaseibacillus sp., Two Novel Bacterial Strains with Probiotic Potential Isolated from the Mexican Fermented Beverage “Pozol”
Personalised Medicine, Diagnostics, Standardisation
Paul Cotter
Teagasc Food Research Center, Ireland
Fermented Foods and Potential Contributions to Personalised Nutrition
Remco Kort
Vrije Universiteit Amsterdam, the Netherlands
Understanding Probiotic Properties of the Human Vaginal Bacterium Lactobacillus crispatus
Yosep Ji
HEM Pharma, South Korea
Understanding Microbiome for Personalized Approach
Dennis Zeilstra
Microbiome Center, the Netherlands
Integration of Evidence-Based Medicine and Personalized Medicine in Personalized Microbiome Treatments
Koen Venema
Beneficial Microbes Consultancy, the Netherlands
Personalized Nutrition Advice to Optimize Gut Microbiota Composition – Results of the Friends & Family Study
Coffee Break
Andrea Laukova
Institute of Animal Physiology, Slovakia
Enterocins and Their Application Potential in Animal Breeding
Sune K. Jensen
University of Copenhagen, Denmark
Oral hBD2 Administration Requires a Functional Gut Microbiota to Mitigate Cigarette Smoke-Induced Lung Inflammation
Monika Pogány Simonova
Institute of Animal Physiology, Slovakia
Bacteriocins – a New Approach to Increase Products Quality of Food-producing Animals
Santosh Tiwari
Maharshi Dayanand University, India
Halocins of Haloarchaea: Antimicrobial Peptides with Extreme Stability under Diverse Conditions
12:50 – 13:50
Lunch Break
Lunch Break
Postbiotics
Arthur C. Ouwehand
International Flavors & Fragrances, Finland
Where Do Probiotics Go When They Die? A Short Introduction to Postbiotics
Simone Guglielmetti
Università degli Studi di Milano, Italy
Bridging Research and Industry on Health-Promoting Agents from Non-Viable Microbes: Toward a Shared Consensus on Terminology and Definitions
Wilbert Sybesma
Microbiome Solutions, Switzerland
Postbiotics – Mechanisms of Actions and Where this Field Is Going to
Eva Armengol
Scientific Manager at AB-BIOTICS, Spain
Applicability of Postbiotics: A New World to Discover
Animal Health Symposium
Gert Folkerts
Utrecht Institute for Pharmaceutical Sciences, the Netherlands
Galacto-Oligosaccharides Alleviate Lung Inflammation by Inhibiting NLRP3 Inflammasome Activation in Vivo and in Vitro
Ivan Rychlik
Veterinary Research Institute, Brno, Czech Republic
Chicken and Environmental Microbiota
Viviana Molnar-Nagy
Dr. Bata Ltd, R&D, Ócsa, Hungary
Highly Effective Probiotic-based Feed Additive Against Digestive Disorders in Conventional Broiler Rearing
15:45 – 16:15
Coffee Break
Coffee Break
Postbiotics – Panel Discussion
Moderator: Arthur Ouwehand
Panelists: Wilbert Sybesma
Simone Guglielmetti
Eva Armengol
Philippe Langella
George Paraskevakos
20:00…
Conference Dinner on the Boat Restaurant
Informal Discussions Continues
Thursday, 22 June 2023
09:00 – 10:30
Better Science – Better Studies
Clinical Trials – Selection Criteria,
New Approach to Clinical Studies
Hania Szajewska
Medical University of Warsaw, Poland
Clinical Studies – How to Read and Evaluate?
Robert JM Brummer
Örebro University and University Hospital, Sweden
Pro- and Prebiotics for Improved Mental Health – How Does it Work and How Do We Measure It?
Prebiotics
Maria Wiese
TNO, the Netherlands
Structure and Function of Non-digestible Carbohydrates in the Gut Microbiome
Yala Stevens
BioActor BV, Research & Development, Maastricht, Netherlands
10:35 – 11:05
Coffee Break
Yunus Emre Tunçil
Necmettin Erbakan University, Turkey
Bio-Catalytical Syntheses of Non-Digestible α-Glucans with Different Structural Features and Their Impacts on Colonic Microbiota and Metabolic Outputs
Enes Dertli
Yildiz Technical University, Turkey
A Glucansucrase Based Engineering to Produce Novel Poly-Oligosaccharides with Prebiotic Functions
Marina Elli
Coree Srl, R&D, Milan, Italy
Fermentation of Oat Beverage by Probiotic Blends and Assessment of Their Impact on the Absorption Profiles
Valentina Taverniti
SACCO SYSTEM, Italy
Gut microbiota modulation by probiotics improves inflammaging
Yuri Lee
Handong Global University, South Korea
The Beneficial Effect of Bifidobacterium animalis subsp. lactis HEM20-01 in a Chronic Unpredictable Mild Stress and LPS (CUMSLPS)-induced Depressive-like Mouse Model by Modulating the Gut Microbiota and the Gut Metabolites
Erwin Geroleo
Jose R. Reyes Mem. Medical Center, Philippines
The Effectiveness of Probiotics in the Treatment of Minimal Hepatic Encephalopathy (MHE) among Patients with Cirrhosis: An Expanded Meta-Analysis
Wenrui Li
Nanyang Technological University, Singapore
Ex Vivo Evaluation of the Polysaccharide-Encapsulated, Host-Derived Microbial Compositions on the Gut Microbiota of Jade Perch (Scortum barcoo)
Meryem Boujnane
Université de Rouen Normandie, France
Inter-Kingdom Signaling of Stress Hormones: Sensing and Modulation of Pathogens/Probiotics/Host Interactions?
12:45 – 13:45
Lunch Break
Gut-Health axis (brain, skin, lung, liver, joint)
Anna Chwalibóg
Integral Solutions, Poland
Precision Microbiome-Based Therapeutics Using CRISPR Genome Engineering
Amine Zorgani
S-Biomedic, JLABS, Belgium
Topical Probiotics in Skin Barrier Function – Report on a Double-Blinded Placebo Controlled Pilot Study in Stressed Skin with Live Cutibacterium acnes
Laura Huuskonen
IFF Health & Biosciences, Finland
Effects of Bifidobacterium animalis subsp. lactis Bl-04 on Skin Wrinkles and Dryness: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial
Petr Ryšávka
Probiotics&Microbiome Innovations, Czech Republic
Development of a Topical Cosmetic Product Containing Live Probiotic Cultures
Hiroshi Ohno
RIKEN Center for Integrative Medical Sciences, Japan
Smoking Modulates Gut Ecosystem of Patients with Inflammatory Bowel Diseases to Attenuate Ulcerative Colitis while Exacerbate Crohn’s Disease
Thomas Berngruber
Evonik Operations, Creavis – Life Science, Germany
Specialized Pro-Resolving Lipid Mediators (SPMs) from Synbiotic Application of Bacillus megaterium DSM 32963 and Polyunsaturated Fatty Acid (PUFA) Lysin-Salts Counteract Inflammation in Ex-Vivo Colon Biopsies of IBD Patients
15:30 – 16:00
Coffee Break
Young Scientists Award
Best Poster Award
End of the Conference
Viktor Bielik
Comenius University Bratislava, Slovakia
The Combination of Probiotics and Physical Training on Gut Microbiota and Metabolomics
Mariya Peneva
Medical Center “Eurozdrave-Bulgaria”, Bulgaria
Application of Probiotic Formula, Containing Lactobacillus Bulgaricus DWT1 in Patients with COVID-19
Technology, Production(costs), Good practices, Efficacy, Rehydration
Elisa Salvetti
University of Verona, Italy
What is New in Taxonomy
Jiri Snaidr
Vermicon AG, Microbiology, Germany
The Power of Fluorescence In Situ Hybridisation – How FISH Changes Enumeration and Quality Control of Probiotics and Enables Spatial Microbiome Analysis
Ioannis Vrasidas
the TIM Company, the Netherlands
TIM in Vitro Dynamic Gastrointestinal Model and Applications Thereof in Pre- and Probiotic Related Studies
Ilia Belotserkovsky
BIOASTER, Microbiota Program, France
Ex-Vivo Experimental Approaches to Explore the Immunomodulatory and Homeostatic Potential of Prebiotics and Probiotics
18:00
Farewell Drink